These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37361592)

  • 21. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
    Culp SH; Schellhammer PF; Williams MB
    Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.
    Gravis G; Boher JM; Chen YH; Liu G; Fizazi K; Carducci MA; Oudard S; Joly F; Jarrard DM; Soulie M; Eisenberger MJ; Habibian M; Dreicer R; Garcia JA; Hussain MHM; Kohli M; Vogelzang NJ; Picus J; DiPaola R; Sweeney C
    Eur Urol; 2018 Jun; 73(6):847-855. PubMed ID: 29475737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and oncologic findings of extraprostatic extension on needle biopsy in
    Chen JR; Zhao JG; Zhu S; Zhang MN; Chen N; Liu JD; Sun GX; Shen PF; Zeng H
    Asian J Androl; 2020; 22(4):427-431. PubMed ID: 31424026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis.
    Antwi S; Everson TM
    Cancer Epidemiol; 2014 Aug; 38(4):435-41. PubMed ID: 24802851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
    Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
    Xu Y; Huang T; Mao M; Zhai J; Chen J
    Laryngoscope; 2021 Apr; 131(4):E1130-E1138. PubMed ID: 32833262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
    Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience.
    Wee CE; Costello BA; Orme JJ; Quevedo JF; Pagliaro LC
    Prostate; 2021 Sep; 81(13):938-943. PubMed ID: 34254332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of primary large cell neuroendocrine carcinoma of the prostate.
    Nguyen N; Franz RD; Mohammed O; Huynh R; Son CK; Khan RN; Ahmed B
    Front Oncol; 2024; 14():1341794. PubMed ID: 38515575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases.
    Zhang Q; Han Y; Zhang Y; Liu D; Ming J; Huang B; Qiu X
    Front Oncol; 2020; 10():571308. PubMed ID: 33598420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
    Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
    Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
    Wu T; Zhao J; Liu Z; Shen P; Zhang M; Sun G; Liu J; Liao B; Chen J; Zhu S; Dai J; Wang Z; Zhang H; Zhao P; Zhang X; Zhu X; Ni Y; Chen N; Zeng H
    Prostate; 2019 Oct; 79(14):1673-1682. PubMed ID: 31433509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study.
    Wang S; Chen L; Chen D; Chao J; Shao Y; Tang K; Chen W
    Cancer Control; 2021; 28():10732748211066309. PubMed ID: 34910613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone metastatic cancer of unknown primary at initial presentation.
    Matsuoka M; Onodera T; Yokota I; Iwasaki K; Suzuki Y; Masanari H; Kondo E; Iwasaki N
    Clin Transl Oncol; 2024 Feb; 26(2):461-467. PubMed ID: 37395989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
    Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
    Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.
    Knipper S; Preisser F; Mazzone E; Mistretta FA; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Jun; 17(3):231-237.e2. PubMed ID: 31080021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival with postoperative radiotherapy in thymic carcinoma: A propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database.
    Lim YJ; Song C; Kim JS
    Lung Cancer; 2017 Jun; 108():161-167. PubMed ID: 28625630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.
    Tu X; Chang T; Nie L; Qiu S; Xu H; Huang Y; Bao Y; Liu Z; Yang L; Wei Q
    Urol Int; 2019; 103(4):383-390. PubMed ID: 30965328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.
    Lin J; Zhao Y; Zhou Y; Tian Y; He Q; Lin J; Hao H; Zou B; Jiang L; Zhao G; Lin W; Xu Y; Li Z; Xue F; Li S; Fu W; Li Y; Xu Z; Li Y; Chen J; Zhou X; Zhu Z; Cai L; Li E; Li H; Zheng C; Li P; Huang C; Xie J
    JAMA Netw Open; 2021 Jul; 4(7):e2114180. PubMed ID: 34313744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score-matching study.
    Zhou Z; Ge H; Li Y; Wang D; Güngör C
    PLoS One; 2022; 17(6):e0270608. PubMed ID: 35749551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.